These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 25224570

  • 1. P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer.
    Shariat S, Badiee A, Jalali SA, Mansourian M, Yazdani M, Mortazavi SA, Jaafari MR.
    Cancer Lett; 2014 Dec 01; 355(1):54-60. PubMed ID: 25224570
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer.
    Zamani P, Navashenaq JG, Nikpoor AR, Hatamipour M, Oskuee RK, Badiee A, Jaafari MR.
    J Control Release; 2019 Jun 10; 303():223-236. PubMed ID: 30999007
    [Abstract] [Full Text] [Related]

  • 8. Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
    Alipour Talesh G, Ebrahimi Z, Badiee A, Mansourian M, Attar H, Arabi L, Jalali SA, Jaafari MR.
    Immunol Lett; 2016 Aug 10; 176():57-64. PubMed ID: 27260485
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids.
    Yazdani M, Jalali SA, Badiee A, Shariat S, Mansourian M, Arabi L, Abbasi A, Saberi Z, Jaafari MR.
    Curr Drug Deliv; 2017 Aug 10; 14(4):492-502. PubMed ID: 27411392
    [Abstract] [Full Text] [Related]

  • 10. Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects.
    Shariat S, Badiee A, Amir Jalali S, Mansourian M, Alireza Mortazavi S, Reza Jaafari M.
    Iran J Basic Med Sci; 2015 May 10; 18(5):506-13. PubMed ID: 26124938
    [Abstract] [Full Text] [Related]

  • 11. Preparation of nanoliposomes linked to HER2/neu-derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer.
    Rastakhiz S, Yazdani M, Shariat S, Arab A, Momtazi-Borojeni AA, Barati N, Mansourian M, Amin M, Abbasi A, Saberi Z, Jalali SA, Badiee A, Jaafari MR.
    J Cell Biochem; 2019 Feb 10; 120(2):1294-1303. PubMed ID: 30378147
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cytotoxic activity of spleen lymphocytes in BALB/c mice immunized by HSP110-HER2/neu ICD].
    Han D, Xu H, Yan WQ.
    Zhonghua Zhong Liu Za Zhi; 2012 Jan 10; 34(1):11-4. PubMed ID: 22490848
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice.
    Wang L, Xie Y, Ahmed KA, Ahmed S, Sami A, Chibbar R, Xu Q, Kane SE, Hao S, Mulligan SJ, Xiang J.
    Breast Cancer Res Treat; 2013 Jul 10; 140(2):273-84. PubMed ID: 23881522
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
    Ravindran R, Maji M, Ali N.
    Mol Pharm; 2012 Jan 01; 9(1):59-70. PubMed ID: 22133194
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes.
    Chang JS, Choi MJ, Kim TY, Cho SY, Cheong HS.
    Vaccine; 1999 Mar 17; 17(11-12):1540-8. PubMed ID: 10195791
    [Abstract] [Full Text] [Related]

  • 19. Effect of monophosphoryl lipid A on antibody response to diphtheria toxin and its subunits.
    Caglar K, Aybay C, Ataoglu H.
    APMIS; 2005 Apr 17; 113(4):256-63. PubMed ID: 15865606
    [Abstract] [Full Text] [Related]

  • 20. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes.
    Zhou F, Huang L.
    Vaccine; 1993 Apr 17; 11(11):1139-44. PubMed ID: 8249434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.